Calcium Electroporation for Stomach Cancer Bleeding
Part of Cancer, Digestive system clinical trials.
This trial tests a minimally invasive endoscopic procedure called calcium electroporation to stop bleeding caused by stomach cancer. It may help patients who cannot have surgery or chemotherapy, or those experiencing bleeding while undergoing cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Stomach cancer confirmed by biopsy
- Anemia (low red blood cells) and/or bleeding from your stomach due to cancer
- Not a good candidate for surgery or chemotherapy due to advanced age, frailty, or serious health conditions, OR have metastatic cancer (spread elsewhere), OR are declining surgery, OR are on chemo and bleeding is interrupting treatment
- Able and willing to provide written consent
- No pregnancy, pacemaker/heart defibrillator (unless it can be temporarily turned off), bleeding disorders, or life expectancy under 1 month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with advanced or metastatic stomach cancer that is also bleeding. It looks at how well initial treatments like chemotherapy or immunotherapy work, without having had stomach surgery first.
This trial uses a freezing technique (cryoablation) combined with an immunotherapy drug (PD-1 inhibitor) for people with advanced stomach cancer that has spread or cannot be removed by surgery. It's for those whose cancer has continued to grow after one or two types of chemotherapy.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
This trial tests whether electroacupuncture (tiny needles with electrical stimulation) can help your stomach work normally again after digestive tract cancer surgery. Many patients experience delayed stomach emptying after surgery, and this study explores whether this traditional treatment may improve digestion and symptoms.
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This trial studies blood-based biomarkers to help doctors choose the best individualized surgical treatment for gastroesophageal junction adenocarcinoma. If you qualify, you’ll get standard care plus additional testing to see whether the blood results can guide surgery more precisely.
Hear when a new Calcium Electroporation for Hemostasis in Gastric Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.